Evidence map›Paper›PMID 38396644›Full record

ArticleInternational journal of molecular sciences2024

Identification of Germline

Carolina Pires, Ana Saramago, Margarida M Moura, Jing Li, Sara Donato, Inês J Marques, Hélio Belo, Ana C Machado, Rafael Cabrera, Thomas G P Grünewald and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Carolina PiresUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Ana SaramagoUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Margarida M MouraUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.ORCID 0000-0002-2390-5473
Jing LiHopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
Sara DonatoServiço de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Inês J MarquesUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.ORCID 0000-0003-0427-7739
Hélio BeloUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Ana C MachadoServiço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Rafael CabreraServiço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Thomas G P GrünewaldHopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.ORCID 0000-0003-0920-7377
Valeriano LeiteUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Branca M CavacoUnidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), 1099-023 Lisboa, Portugal.
Instituto Português de Oncologia de Coimbra Francisco Gentil · PTGerman Cancer Research Center · DE

Funding

Associated Laboratory LS4FUTURE LA/P/0087/2020Barbara and Wilfried Mohr foundationFundação para a Ciência e Tecnologia 2020.07120.BDiNOVA4Health R&D Unit UIDB/04462/2020, UIDP/04462/2020Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG)Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (SPEDM)
6 · The paper itself

Abstract

Germline variants in the FOXE1 transcription factor have been associated with thyroid ectopy, cleft palate (CP) and thyroid cancer (TC). Here, we aimed to clarify the role of

Indexed as

Cleft PalateDermoid CystForkhead Transcription FactorsOvarian NeoplasmsStruma OvariiThyroid NeoplasmsAnimalsFemaleHumansRatsForkhead Transcription FactorsFOXE1 protein, humanFoxE1 protein, ratAXIN1BRAFcleft palateFOXE1genomicsmalignant struma ovariimolecular tumour pathologynext-generation sequencingthyroid cancerthyroid ectopy

Identifiers

PMID38396644
PMCPMC10888156
OpenAlexW4391575382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.